Search Results for “” – Page 47 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes

598 Publications found

Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.

b

Clinical chemistry

December 1, 2015

p Cardiovascular Disease

c Clinical outcomes Meta-analysis
Excess Mortality among Persons with Type 2 Diabetes.

b

The New England journal of medicine

October 29, 2015

p Diabetes

c Change patient management Clinical outcomes Observational Operational efficiencies
Cardiac Troponin Elevation and Outcome after Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis.

b

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

October 1, 2015

p Cardiovascular Disease

c Clinical outcomes Meta-analysis Review
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

b

The oncologist

September 1, 2015

p Cancer

c Change patient management Clinical outcomes Observational
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial.

b

The Journal of antimicrobial chemotherapy

August 1, 2015

p Therapeutic drug monitoring

c Change patient management Clinical outcomes RCT
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.

b

International journal of cardiology

July 15, 2015

p Cardiovascular Disease

c Clinical outcomes Meta-analysis Review
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

b

Circulation. Cardiovascular interventions

June 1, 2015

p Cardiovascular Disease

c Clinical outcomes RCT
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.

b

Cancer medicine

June 1, 2015

p Cancer

c Change patient management Clinical outcomes Observational
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.

b

Gastroenterology

June 1, 2015

p Therapeutic drug monitoring

c Change patient management Clinical outcomes RCT
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

b

Lung cancer (Amsterdam, Netherlands)

May 1, 2015

p Cancer

c Clinical outcomes Economics Model